The majority of the remaining assets and liabilities of the AMS business, which are related to the Astora business, are classified as held for sale in the Consolidated Balance Sheets as of December 31, 2015. The Company will cease business operations for Astora by March 31, 2016. The Company is now actively conducting a wind down process and working to efficiently transition physicians to alternative products. ![]() On February 24, 2016, the Company’s Board of Directors decided to wind down Astora business operations in order to begin bringing finality to the Company’s mesh-related product liability. Consequently, you should not consider this to be a complete discussion of all potential risks or uncertainties. You should understand that it is not possible to predict or identify all such factors. We note these factors for investors as permitted by Section 27A of the Securities Act and Section 21E of the Exchange Act. These are factors that, individually or in the aggregate, we think could cause our actual results to differ materially from expected and historical results. , we provide a cautionary discussion of the risks, uncertainties and possibly inaccurate assumptions relevant to our business. You are advised to consult any further disclosures we make on related subjects in our reports filed with the Securities and Exchange Commission (SEC) and with securities regulators in Canada on the System for Electronic Document Analysis and Retrieval (SEDAR). We do not undertake any obligation to update our forward-looking statements after the date of this document for any reason, even if new information becomes available or other events occur in the future, except as may be required under applicable securities law. of this report "Risk Factors", supplement, and as otherwise enumerated herein, could affect our future financial results and could cause our actual results to differ materially from those expressed in forward-looking statements contained or incorporated by reference in this document. ![]() Investors should note that many factors, as more fully described in Part I, Item 1A. Because these statements reflect our current views concerning future events, these forward-looking statements involve risks and uncertainties. We have based these forward-looking statements on our current expectations and projections about the growth of our business, our financial performance and the development of our industry. ![]() We have tried, whenever possible, to identify such statements by words such as “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plan,” “projected,” “forecast,” “will,” “may” or similar expressions. Forward-looking statements include the information concerning our possible or assumed results of operations. These statements, including estimates of future revenues, future expenses, future net income and future net income per share, contained in the section titled “ Management’s Discussion and Analysis of Financial Condition and Results of Operations ,” which is included in this document, are subject to risks and uncertainties. Statements contained or incorporated by reference in this document contain information that includes or is based on “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |